Eagle Pharmaceuticals
EGRX
#8886
Rank
C$75.05 M
Marketcap
$5.79
Share price
-0.23%
Change (1 day)
-71.87%
Change (1 year)

Operating Margin for Eagle Pharmaceuticals (EGRX)

Operating Margin as of September 2024 (TTM): 13.84%

According to Eagle Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is 13.84%. At the end of 2022 the company had an Operating Margin of 19.40%.

Operating Margin history for Eagle Pharmaceuticals from 2013 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
202219.40%-831.88%
2021-2.65%-121.96%
202012.07%7.53%
201911.23%-29.63%
201815.96%-48.22%
201730.82%9.29%
201628.20%625.47%
20153.89%-103.85%
2014-100.91%98.69%
2013-50.79%-93.61%
2012-794.17%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
17.68% 27.75%๐Ÿ‡บ๐Ÿ‡ธ USA
15.88% 14.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
22.30% 61.13%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-3.93%-128.40%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
11.39%-17.70%๐Ÿ‡บ๐Ÿ‡ธ USA
23.09% 66.84%๐Ÿ‡บ๐Ÿ‡ธ USA
-13.80%-199.71%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.